You just read:

Daiichi Sankyo and Translational Sciences Conclude Agreement, after Successful Phase 1a Trial, as Part of Daiichi Sankyo Portfolio Prioritization

News provided by

Daiichi Sankyo

Dec 01, 2017, 08:00 ET